SO
IBIO icon

STRS Ohio’s iBio IBIO Stock Holding History

STRS Ohio’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$27K – 2235
2020
Q2 		$27K Buy
+25
New +$16.3K ﹤0.01% 2006

Other funds holding IBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

STRS Ohio's IBIO Position: Q3 2020 in Review

STRS Ohio sold out of iBio (IBIO) in Q3 2020, closing a stake of 25 shares — an estimated $27K sold.

STRS Ohio first reported a position in IBIO in Q2 2020 and held it in 1 quarter. The position peaked at $27K in Q2 2020. 77 funds tracked by Wall St. Rank hold IBIO as of Q3 2020.

  • STRS Ohio reported no remaining iBio position as of Q3 2020 after selling out during the quarter.
  • STRS Ohio sold 25 iBio shares in Q3 2020, an estimated $27K.
  • STRS Ohio first reported a position in iBio in Q2 2020 and held it in 1 quarter.
  • STRS Ohio's iBio position peaked at $27K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held iBio as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.